| Value | ₹5.51 Cr |
|---|---|
| Execution period | 4 years vesting |
BSE filing, NSE: MAXESTATES. Summary written from the filing by ALFA Finder's alert engine.
Max Estates Ltd: key numbers
- Share price
- ₹515.60
- Market cap
- ₹8,434 Cr
- Revenue (annual)
- ₹199.4 Cr
- Net profit (annual)
- ₹12.51 Cr
- P/E (TTM)
- 729.4×Sector 33.7×
- Promoter holding
- 45.23%-0.03% QoQ
- FII holding
- 26.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Max Estates Ltd
All →Max Estates Management Change
Max Estates Limited announced the resignation of Mr. Dharmender Kumar, Director & Chief Corporate Affairs Officer, effective from the close of business hours on October 21, 2026.
Max Estates Other Announcement
The company submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI regulations.
Max Estates Legal & Regulatory
Max Estates received a GST show cause notice proposing ₹2.59 Crore in tax, interest and penalty for FY23. No final order passed yet.
- Value
- ₹2.59 Cr
Max Estates Business Update
Max Estates reported ~₹3,200 Crore pre-sales in H1FY2027, with Q2 at ~₹2,100 Crore (1,246% YoY). The NCR developer sold 274 units in the quarter, up 11x year-on-year.
- Value
- ₹3,200 Cr
Max Estates Other Announcement
Max Estates Limited received a Dual 5-Star rating in the 2026 GRESB Real Estate Assessment. The company ranked No. 1 among peer entities in the Development category.
Max Estates Annual General Meeting
Max Estates held an EGM on September 24, 2026, to transact items related to a proposed land acquisition and a preferential issue of equity shares.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date